{
      "Rank": 268,
      "Acronym": [],
      "AgreementOtherDetails": [],
      "AgreementPISponsorEmployee": [],
      "AgreementRestrictionType": [],
      "AgreementRestrictiveAgreement": [],
      "ArmGroupDescription": [
            "On the basis conventional symptomatic treatment and supportive therapy, P-MMSCs were given at 1 million cells/kg body weight/ time, once every 3 days for a total of 3 times: Day \"1\", Day \"4\", Day \"7\".",
            "Conventional symptomatic treatments such as antibacterial (ceftriaxone, azithromycin), anticoagulants, hormones, oxygen therapy, mechanical ventilation and other supportive therapies"
      ],
      "ArmGroupInterventionName": [
            "Procedure: Placenta-Derived MMSCs; Cryopreserved Placenta-Derived Multipotent Mesenchymal Stromal Cells",
            "Drug: Antibiotics",
            "Drug: Hormones",
            "Drug: Anticoagulant Therapy",
            "Device: \u041exygen therapy",
            "Drug: Antibiotics",
            "Drug: Hormones",
            "Drug: Anticoagulant Therapy",
            "Device: \u041exygen therapy"
      ],
      "ArmGroupLabel": [
            "Experimental group",
            "Control Group"
      ],
      "ArmGroupType": [
            "Experimental",
            "Active Comparator"
      ],
      "AvailIPDComment": [],
      "AvailIPDId": [],
      "AvailIPDType": [],
      "AvailIPDURL": [],
      "BaselineCategoryTitle": [],
      "BaselineClassDenomCountGroupId": [],
      "NCTId": [
            "NCT04461925"
      ],
      "BaselineClassDenomCountValue": [],
      "BaselineClassDenomUnits": [],
      "BaselineClassTitle": [],
      "BaselineDenomCountGroupId": [],
      "BaselineDenomCountValue": [],
      "BaselineDenomUnits": [],
      "BaselineGroupDescription": [],
      "BaselineGroupId": [],
      "BaselineGroupTitle": [],
      "BaselineMeasureCalculatePct": [],
      "BaselineMeasureDenomCountGroupId": [],
      "BaselineMeasureDenomCountValue": [],
      "BaselineMeasureDenomUnits": [],
      "BaselineMeasureDenomUnitsSelected": [],
      "BaselineMeasureDescription": [],
      "BaselineMeasureDispersionType": [],
      "BaselineMeasureParamType": [],
      "BaselineMeasurePopulationDescription": [],
      "BaselineMeasureTitle": [],
      "BaselineMeasureUnitOfMeasure": [],
      "BaselineMeasurementComment": [],
      "BaselineMeasurementGroupId": [],
      "BaselineMeasurementLowerLimit": [],
      "BaselineMeasurementSpread": [],
      "BaselineMeasurementUpperLimit": [],
      "BaselineMeasurementValue": [],
      "BaselinePopulationDescription": [],
      "BaselineTypeUnitsAnalyzed": [],
      "BioSpecDescription": [],
      "BioSpecRetention": [],
      "BriefSummary": [
            "Assessment of the clinical effects of infusions of cryopreserved allogeneic multipotent mesenchymal stem cells of the placenta and umbilical cord for COVID-19 patients with acute respiratory distress syndrome."
      ],
      "BriefTitle": [
            "Treatment of Coronavirus COVID-19 Pneumonia (Pathogen SARS-CoV-2) With Cryopreserved Allogeneic P_MMSCs and UC-MMSCs"
      ],
      "CentralContactEMail": [
            "nemtinov@stemcellclinic.com",
            "ustimenko@stemcellclinic.com"
      ],
      "CentralContactName": [
            "Peter Nemtinov, MD",
            "Alina Ustymenko, PhD"
      ],
      "CentralContactPhone": [
            "+380442079207",
            "+380442079207"
      ],
      "CentralContactPhoneExt": [],
      "CentralContactRole": [
            "Contact",
            "Contact"
      ],
      "CollaboratorClass": [
            "UNKNOWN"
      ],
      "CollaboratorName": [
            "Kyiv City Clinical Hospital # 4"
      ],
      "CompletionDate": [
            "December 2021"
      ],
      "CompletionDateType": [
            "Anticipated"
      ],
      "Condition": [
            "COVID-19 Pneumonia"
      ],
      "ConditionAncestorId": [
            "D000012141",
            "D000007239",
            "D000011024",
            "D000014777",
            "D000018352",
            "D000003333",
            "D000030341",
            "D000012327",
            "D000008171",
            "D000012140"
      ],
      "ConditionAncestorTerm": [
            "Respiratory Tract Infections",
            "Infections",
            "Pneumonia, Viral",
            "Virus Diseases",
            "Coronavirus Infections",
            "Coronaviridae Infections",
            "Nidovirales Infections",
            "RNA Virus Infections",
            "Lung Diseases",
            "Respiratory Tract Diseases"
      ],
      "ConditionBrowseBranchAbbrev": [
            "BC01",
            "BC08",
            "All",
            "BC23"
      ],
      "ConditionBrowseBranchName": [
            "Infections",
            "Respiratory Tract (Lung and Bronchial) Diseases",
            "All Conditions",
            "Symptoms and General Pathology"
      ],
      "ConditionBrowseLeafAsFound": [
            "COVID-19",
            "Pneumonia"
      ],
      "ConditionBrowseLeafId": [
            "M2562",
            "M13056",
            "M19643",
            "M9435",
            "M14130",
            "M5520",
            "M13066",
            "M16674",
            "M5707",
            "M22838",
            "M14301",
            "M10320",
            "M14129"
      ],
      "ConditionBrowseLeafName": [
            "COVID-19",
            "Pneumonia",
            "Coronavirus Infections",
            "Infections",
            "Respiratory Tract Infections",
            "Communicable Diseases",
            "Pneumonia, Viral",
            "Virus Diseases",
            "Coronaviridae Infections",
            "Nidovirales Infections",
            "RNA Virus Infections",
            "Lung Diseases",
            "Respiratory Tract Diseases"
      ],
      "ConditionBrowseLeafRelevance": [
            "high",
            "high",
            "low",
            "low",
            "low",
            "low",
            "low",
            "low",
            "low",
            "low",
            "low",
            "low",
            "low"
      ],
      "ConditionMeshId": [
            "D000086382",
            "D000011014"
      ],
      "ConditionMeshTerm": [
            "COVID-19",
            "Pneumonia"
      ],
      "DelayedPosting": [],
      "DesignAllocation": [
            "Non-Randomized"
      ],
      "DesignInterventionModel": [
            "Parallel Assignment"
      ],
      "DesignInterventionModelDescription": [
            "Experimental: stem cells therapy + treatment in according with approved by Ukrainian Health Ministry COVID-19 clinical protocol Experimental Group 1: Subjects with severe COVID-19 pneumonia shall be received three infusions of cryopreserved allogeneic P-MMSCs (1 million cells/kg body weight) at 2-days intervals: Day \"1\", Day \"4\", Day \"7\".\n\nControl Group: treatment in according with approved by Ukrainian MoH COVID-19 clinical protocol."
      ],
      "DesignMasking": [
            "None (Open Label)"
      ],
      "DesignMaskingDescription": [],
      "DesignObservationalModel": [],
      "DesignPrimaryPurpose": [
            "Treatment"
      ],
      "DesignTimePerspective": [],
      "DesignWhoMasked": [],
      "DetailedDescription": [
            "Currently, cell-based therapy and especially stem cell therapy has become a promising therapeutic field, in which many see opportunities to cure incurable diseases. Severe respiratory consequences of the COVID-19, the disease caused by the novel SARS-CoV-2 coronavirus, have prompted urgent need for novel therapies.\n\nCell-based approaches, primarily using mesenchymal stem cells (MSCs), have demonstrated safety and efficacy in patients with the acute respiratory distress syndrome (ARDS) - common manifestation of cytokine storms, and the cause of death in many COVID-19 patients.\n\nMesenchymal stem cells are a powerful immunomodulator, they secrete many anti-inflammatory biologically active substances (cytokines) that reduce the inflammatory process in the lungs. Also mesenchymal stem cells secrete numerous growth factors that contribute to the recovery of not only the affected lung tissue but also other organs."
      ],
      "DispFirstPostDate": [],
      "DispFirstPostDateType": [],
      "DispFirstSubmitDate": [],
      "DispFirstSubmitQCDate": [],
      "EligibilityCriteria": [
            "Inclusion Criteria:\n\nMale or female, aged at 18 years (including) - 75 years old.\nLaboratory confirmation of SARS-CoV-2 infection by reverse-transcription polymerase chain reaction (RT-PCR) from any diagnostic sampling source.\nPneumonia that is judged by X-ray imaging.\n\nIn accordance with any one of the following:\n\ndyspnea (RR \u2265 30 times / min);\nfinger oxygen saturation \u2264 93% in resting state;\narterial oxygen partial pressure (PaO2) / oxygen absorption concentration (FiO2) \u2264 300MMHG (if possible);\ninvasive ventilation< 48 h.\n\nExclusion Criteria:\n\nMale or female, aged at <18 years and > 75 years old.\nPregnancy, lactation and those who are not pregnant but do not take effective contraceptives measures.\nPatients with malignant tumor, other serious systemic diseases and psychosis.\nPatients who are participating in other clinical trials.\nInability to provide informed consent or to comply with test requirements.\nCo-Infection of HIV, syphilis.\nInvasive ventilation > 48 h.\nCombined with other organ failure (need organ support)."
      ],
      "EnrollmentCount": [
            "30"
      ],
      "EnrollmentType": [
            "Anticipated"
      ],
      "EventGroupDeathsNumAffected": [],
      "EventGroupDeathsNumAtRisk": [],
      "EventGroupDescription": [],
      "EventGroupId": [],
      "EventGroupOtherNumAffected": [],
      "EventGroupOtherNumAtRisk": [],
      "EventGroupSeriousNumAffected": [],
      "EventGroupSeriousNumAtRisk": [],
      "EventGroupTitle": [],
      "EventsDescription": [],
      "EventsFrequencyThreshold": [],
      "EventsTimeFrame": [],
      "ExpAccTypeIndividual": [],
      "ExpAccTypeIntermediate": [],
      "ExpAccTypeTreatment": [],
      "ExpandedAccessNCTId": [],
      "ExpandedAccessStatusForNCTId": [],
      "FDAAA801Violation": [],
      "FlowAchievementComment": [],
      "FlowAchievementGroupId": [],
      "FlowAchievementNumSubjects": [],
      "FlowAchievementNumUnits": [],
      "FlowDropWithdrawComment": [],
      "FlowDropWithdrawType": [],
      "FlowGroupDescription": [],
      "FlowGroupId": [],
      "FlowGroupTitle": [],
      "FlowMilestoneComment": [],
      "FlowMilestoneType": [],
      "FlowPeriodTitle": [],
      "FlowPreAssignmentDetails": [],
      "FlowReasonComment": [],
      "FlowReasonGroupId": [],
      "FlowReasonNumSubjects": [],
      "FlowReasonNumUnits": [],
      "FlowRecruitmentDetails": [],
      "FlowTypeUnitsAnalyzed": [],
      "Gender": [
            "All"
      ],
      "GenderBased": [],
      "GenderDescription": [],
      "HasExpandedAccess": [
            "No"
      ],
      "HealthyVolunteers": [
            "No"
      ],
      "IPDSharing": [],
      "IPDSharingAccessCriteria": [],
      "IPDSharingDescription": [],
      "IPDSharingInfoType": [],
      "IPDSharingTimeFrame": [],
      "IPDSharingURL": [],
      "InterventionAncestorId": [
            "D000000893",
            "D000000932",
            "D000001337",
            "D000018373",
            "D000045505",
            "D000005765",
            "D000005938",
            "D000006730",
            "D000018931",
            "D000000970",
            "D000045504",
            "D000000890",
            "D000005343",
            "D000050299"
      ],
      "InterventionAncestorTerm": [
            "Anti-Inflammatory Agents",
            "Antiemetics",
            "Autonomic Agents",
            "Peripheral Nervous System Agents",
            "Physiological Effects of Drugs",
            "Gastrointestinal Agents",
            "Glucocorticoids",
            "Hormones, Hormone Substitutes, and Hormone Antagonists",
            "Antineoplastic Agents, Hormonal",
            "Antineoplastic Agents",
            "Molecular Mechanisms of Pharmacological Action",
            "Anti-Infective Agents",
            "Fibrinolytic Agents",
            "Fibrin Modulating Agents"
      ],
      "InterventionArmGroupLabel": [
            "Experimental group",
            "Control Group",
            "Experimental group",
            "Control Group",
            "Experimental group",
            "Control Group",
            "Experimental group",
            "Control Group",
            "Experimental group"
      ],
      "InterventionBrowseBranchAbbrev": [
            "Infl",
            "ANeo",
            "AnEm",
            "Gast",
            "All",
            "Infe",
            "FiAg",
            "AnCoag"
      ],
      "InterventionBrowseBranchName": [
            "Anti-Inflammatory Agents",
            "Antineoplastic Agents",
            "Antiemetics",
            "Gastrointestinal Agents",
            "All Drugs and Chemicals",
            "Anti-Infective Agents",
            "Fibrinolytic Agents",
            "Anticoagulants"
      ],
      "InterventionBrowseLeafAsFound": [
            "Test",
            "Include",
            "Position",
            "Choice",
            "Colony",
            "Resonance",
            "Chemoradiation"
      ],
      "InterventionBrowseLeafId": [
            "M6254",
            "M8941",
            "M3374",
            "M235540",
            "M19304",
            "M3396",
            "M3376",
            "M136812",
            "M19284",
            "M4845",
            "M3369",
            "M3403",
            "M8033",
            "M8199",
            "M8940",
            "M20119",
            "M3366",
            "M7625"
      ],
      "InterventionBrowseLeafName": [
            "Dexamethasone",
            "Hormones",
            "Anti-Bacterial Agents",
            "Dexamethasone acetate",
            "Enoxaparin",
            "Anticoagulants",
            "Antibiotics, Antitubercular",
            "Enoxaparin sodium",
            "Azithromycin",
            "Ceftriaxone",
            "Anti-Inflammatory Agents",
            "Antiemetics",
            "Gastrointestinal Agents",
            "Glucocorticoids",
            "Hormone Antagonists",
            "Antineoplastic Agents, Hormonal",
            "Anti-Infective Agents",
            "Fibrinolytic Agents"
      ],
      "InterventionBrowseLeafRelevance": [
            "high",
            "high",
            "high",
            "low",
            "high",
            "high",
            "low",
            "low",
            "high",
            "high",
            "low",
            "low",
            "low",
            "low",
            "low",
            "low",
            "low",
            "low"
      ],
      "InterventionDescription": [
            "i/v infusions",
            "per os",
            "a moderate amount of dexamethasone i/v",
            "Sub-Q",
            "\u041exygen therapy, mechanical ventilation and other supportive therapies"
      ],
      "InterventionMeshId": [
            "D000000900",
            "D000017963",
            "D000002443",
            "D000003907",
            "D000017984",
            "D000000925",
            "D000006728"
      ],
      "InterventionMeshTerm": [
            "Anti-Bacterial Agents",
            "Azithromycin",
            "Ceftriaxone",
            "Dexamethasone",
            "Enoxaparin",
            "Anticoagulants",
            "Hormones"
      ],
      "InterventionName": [
            "Placenta-Derived MMSCs; Cryopreserved Placenta-Derived Multipotent Mesenchymal Stromal Cells",
            "Antibiotics",
            "Hormones",
            "Anticoagulant Therapy",
            "\u041exygen therapy"
      ],
      "InterventionOtherName": [
            "P-MMSCs",
            "ceftriaxone and azithromycin capsules",
            "dexamethasone",
            "\u0415noxaparin",
            "\u041exygen insufflation"
      ],
      "InterventionType": [
            "Procedure",
            "Drug",
            "Drug",
            "Drug",
            "Device"
      ],
      "IsFDARegulatedDevice": [
            "No"
      ],
      "IsFDARegulatedDrug": [
            "No"
      ],
      "IsPPSD": [],
      "IsUSExport": [],
      "IsUnapprovedDevice": [],
      "Keyword": [
            "Placenta-derived MMSCs",
            "i/v infusions"
      ],
      "LargeDocDate": [],
      "LargeDocFilename": [],
      "LargeDocHasICF": [],
      "LargeDocHasProtocol": [],
      "LargeDocHasSAP": [],
      "LargeDocLabel": [],
      "LargeDocTypeAbbrev": [],
      "LargeDocUploadDate": [],
      "LastKnownStatus": [
            "Recruiting"
      ],
      "LastUpdatePostDate": [
            "July 8, 2020"
      ],
      "LastUpdatePostDateType": [
            "Actual"
      ],
      "LastUpdateSubmitDate": [
            "July 7, 2020"
      ],
      "LeadSponsorClass": [
            "INDUSTRY"
      ],
      "LeadSponsorName": [
            "Institute of Cell Therapy"
      ],
      "LimitationsAndCaveatsDescription": [],
      "LocationCity": [
            "Kyiv"
      ],
      "LocationContactEMail": [
            "nemtinov@stemcellclinic.com",
            "ustimenko@stemcellclinic.com"
      ],
      "LocationContactName": [
            "Peter Nemtinov, MD",
            "Alina Ustymenko, PhD",
            "Alexey Chibisov, MD"
      ],
      "LocationContactPhone": [
            "+380442079207",
            "+380442079207"
      ],
      "LocationContactPhoneExt": [],
      "LocationContactRole": [
            "Contact",
            "Contact",
            "Principal Investigator"
      ],
      "LocationCountry": [
            "Ukraine"
      ],
      "LocationFacility": [
            "Institute of Cell Therapy"
      ],
      "LocationState": [],
      "LocationStatus": [
            "Recruiting"
      ],
      "LocationZip": [
            "04073"
      ],
      "MaximumAge": [
            "75 Years"
      ],
      "MinimumAge": [
            "18 Years"
      ],
      "NCTIdAlias": [],
      "OfficialTitle": [
            "Treatment of Coronavirus COVID-19 Pneumonia (Pathogen SARS-CoV-2) With Cryopreserved Allogeneic Multipotent Mesenchymal Stem Cells of the Placenta and Umbilical Cord"
      ],
      "OrgClass": [
            "INDUSTRY"
      ],
      "OrgFullName": [
            "Institute of Cell Therapy"
      ],
      "OrgStudyId": [
            "#4/24.04.2020"
      ],
      "OrgStudyIdDomain": [],
      "OrgStudyIdLink": [],
      "OrgStudyIdType": [],
      "OtherEventAssessmentType": [],
      "OtherEventNotes": [],
      "OtherEventOrganSystem": [],
      "OtherEventSourceVocabulary": [],
      "OtherEventStatsGroupId": [],
      "OtherEventStatsNumAffected": [],
      "OtherEventStatsNumAtRisk": [],
      "OtherEventStatsNumEvents": [],
      "OtherEventTerm": [],
      "OtherOutcomeDescription": [],
      "OtherOutcomeMeasure": [],
      "OtherOutcomeTimeFrame": [],
      "OutcomeAnalysisCILowerLimit": [],
      "OutcomeAnalysisCILowerLimitComment": [],
      "OutcomeAnalysisCINumSides": [],
      "OutcomeAnalysisCIPctValue": [],
      "OutcomeAnalysisCIUpperLimit": [],
      "OutcomeAnalysisCIUpperLimitComment": [],
      "OutcomeAnalysisDispersionType": [],
      "OutcomeAnalysisDispersionValue": [],
      "OutcomeAnalysisEstimateComment": [],
      "OutcomeAnalysisGroupDescription": [],
      "OutcomeAnalysisGroupId": [],
      "OutcomeAnalysisNonInferiorityComment": [],
      "OutcomeAnalysisNonInferiorityType": [],
      "OutcomeAnalysisOtherAnalysisDescription": [],
      "OutcomeAnalysisPValue": [],
      "OutcomeAnalysisPValueComment": [],
      "OutcomeAnalysisParamType": [],
      "OutcomeAnalysisParamValue": [],
      "OutcomeAnalysisStatisticalComment": [],
      "OutcomeAnalysisStatisticalMethod": [],
      "OutcomeAnalysisTestedNonInferiority": [],
      "OutcomeCategoryTitle": [],
      "OutcomeClassDenomCountGroupId": [],
      "OutcomeClassDenomCountValue": [],
      "OutcomeClassDenomUnits": [],
      "OutcomeClassTitle": [],
      "OutcomeDenomCountGroupId": [],
      "OutcomeDenomCountValue": [],
      "OutcomeDenomUnits": [],
      "OutcomeGroupDescription": [],
      "OutcomeGroupId": [],
      "OutcomeGroupTitle": [],
      "OutcomeMeasureAnticipatedPostingDate": [],
      "OutcomeMeasureCalculatePct": [],
      "OutcomeMeasureDenomUnitsSelected": [],
      "OutcomeMeasureDescription": [],
      "OutcomeMeasureDispersionType": [],
      "OutcomeMeasureParamType": [],
      "OutcomeMeasurePopulationDescription": [],
      "OutcomeMeasureReportingStatus": [],
      "OutcomeMeasureTimeFrame": [],
      "OutcomeMeasureTitle": [],
      "OutcomeMeasureType": [],
      "OutcomeMeasureTypeUnitsAnalyzed": [],
      "OutcomeMeasureUnitOfMeasure": [],
      "OutcomeMeasurementComment": [],
      "OutcomeMeasurementGroupId": [],
      "OutcomeMeasurementLowerLimit": [],
      "OutcomeMeasurementSpread": [],
      "OutcomeMeasurementUpperLimit": [],
      "OutcomeMeasurementValue": [],
      "OverallOfficialAffiliation": [
            "Institute of Cell Therapy"
      ],
      "OverallOfficialName": [
            "Peter Nemtinov, MD"
      ],
      "OverallOfficialRole": [
            "Study Director"
      ],
      "OverallStatus": [
            "Unknown status"
      ],
      "OversightHasDMC": [
            "Yes"
      ],
      "PatientRegistry": [],
      "Phase": [
            "Phase 1",
            "Phase 2"
      ],
      "PointOfContactEMail": [],
      "PointOfContactOrganization": [],
      "PointOfContactPhone": [],
      "PointOfContactPhoneExt": [],
      "PointOfContactTitle": [],
      "PrimaryCompletionDate": [
            "May 2, 2021"
      ],
      "PrimaryCompletionDateType": [
            "Anticipated"
      ],
      "PrimaryOutcomeDescription": [
            "Improvement of pulmonary function. Arterial oxygen tension PaO2 (in mmHg)/fractional inspired oxygen FiO2 (expressed as a fraction, not a percentage), most conveniently the P/F ratio. The normal P/F ratio is ~ 400-500 mmHg (~55-65 kPa). P/F ratio <300mmHg - sign of Acute Respiratory Distress Syndrome (ARDS)",
            "Length of Hospital Stay",
            "Marker for efficacy of treatment"
      ],
      "PrimaryOutcomeMeasure": [
            "Changes of oxygenation index PaO2/FiO2, most conveniently the P/F ratio.",
            "Changes in length of hospital stay",
            "Changes in mortality rate"
      ],
      "PrimaryOutcomeTimeFrame": [
            "up to 28 days",
            "up to 28 days",
            "up to 28 days"
      ],
      "ReferenceCitation": [],
      "ReferencePMID": [],
      "ReferenceType": [],
      "RemovedCountry": [],
      "ResponsiblePartyInvestigatorAffiliation": [],
      "ResponsiblePartyInvestigatorFullName": [],
      "ResponsiblePartyInvestigatorTitle": [],
      "ResponsiblePartyOldNameTitle": [],
      "ResponsiblePartyOldOrganization": [],
      "ResponsiblePartyType": [
            "Sponsor"
      ],
      "ResultsFirstPostDate": [],
      "ResultsFirstPostDateType": [],
      "ResultsFirstPostedQCCommentsDate": [],
      "ResultsFirstPostedQCCommentsDateType": [],
      "ResultsFirstSubmitDate": [],
      "ResultsFirstSubmitQCDate": [],
      "RetractionPMID": [],
      "RetractionSource": [],
      "SamplingMethod": [],
      "SecondaryId": [],
      "SecondaryIdDomain": [],
      "SecondaryIdLink": [],
      "SecondaryIdType": [],
      "SecondaryOutcomeDescription": [
            "Infection biomarker. Serum CRP levels can be used for early diagnosis of pneumonia, patients with severe pneumonia had high CRP levels.",
            "CT assessment of pulmonary lesions and lung tissue changes",
            "Indirect response to lung function",
            "Degree of infection"
      ],
      "SecondaryOutcomeMeasure": [
            "Changes of \u0421-reactive protein (CRP, mg/L)",
            "Evaluation of Pneumonia Improvement",
            "Duration of respiratory symptoms (difficulty breathing, dry cough, fever, etc.)",
            "Peripheral blood count recovery time"
      ],
      "SecondaryOutcomeTimeFrame": [
            "At baseline, Day 1, Week 1, Week 2, Week 4, Week 8",
            "At baseline, Day 1, Week 1, Week 2, Week 4, Week 8",
            "At baseline, Day 1, Week 1, Week 2, Week 4, Week 8",
            "At baseline, Day 1, Week 1, Week 2, Week 4, Week 8"
      ],
      "SeeAlsoLinkLabel": [],
      "SeeAlsoLinkURL": [],
      "SeriousEventAssessmentType": [],
      "SeriousEventNotes": [],
      "SeriousEventOrganSystem": [],
      "SeriousEventSourceVocabulary": [],
      "SeriousEventStatsGroupId": [],
      "SeriousEventStatsNumAffected": [],
      "SeriousEventStatsNumAtRisk": [],
      "SeriousEventStatsNumEvents": [],
      "SeriousEventTerm": [],
      "StartDate": [
            "May 2, 2020"
      ],
      "StartDateType": [
            "Actual"
      ],
      "StatusVerifiedDate": [
            "June 2020"
      ],
      "StdAge": [
            "Adult",
            "Older Adult"
      ],
      "StudyFirstPostDate": [
            "July 8, 2020"
      ],
      "StudyFirstPostDateType": [
            "Actual"
      ],
      "StudyFirstSubmitDate": [
            "July 1, 2020"
      ],
      "StudyFirstSubmitQCDate": [
            "July 7, 2020"
      ],
      "StudyPopulation": [],
      "StudyType": [
            "Interventional"
      ],
      "SubmissionMCPReleaseN": [],
      "SubmissionReleaseDate": [],
      "SubmissionResetDate": [],
      "SubmissionUnreleaseDate": [],
      "TargetDuration": [],
      "UnpostedEventDate": [],
      "UnpostedEventType": [],
      "UnpostedResponsibleParty": [],
      "VersionHolder": [
            "October 10, 2022"
      ],
      "WhyStopped": []
}